2003•Cancer Chemotherapy and PharmacologyRequires access

Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapy

Kazuhiko Yoshimatsu, Hiroyuki Kato, Keiichiro Ishibashi, Masahiko Hashimoto, Arihiro Umehara, Hajime Yokomizo, Kiyohito Yoshida, Takashi Fujimoto, Kiyo Iwasaki, Kenji Ogawa

Open publisher page 16 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 16 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Irinotecan, Medicine, Chemotherapy, Colorectal cancer, Leukopenia, Cisplatin, Fluorouracil, Internal medicine

Back to paper search Browse research topics Original source

Second-line chemotherapy with low-dose CPT-11 and cisplatin for colorectal cancer resistant to 5-FU-based chemotherapy — Research Paper | ScholarLens